Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SLN compared with ANNX: revenue, margins and what each company keeps, and the suppliers and customers both name
SLN
Silence Therapeutics plc
Change
Mkt cap
Revenue
Revenue
ANNX
Annexon, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
SLN
Silence Therapeutics plc
vs
ANNX
Annexon, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
SLN
Silence Therapeutics plc
Change
19.76
· pre 19.76
· delayed
Mkt cap
$933.1M
Revenue
$422,000
Q1 FY26
Revenue
$559,000
FY25
ANNX
Annexon, Inc.
Change
4.07
· pre 4.09
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$828.0M
Revenue
—
Revenue
—
vs
Compare
Pre-market
Oct 30 '26
delayed
SLN
Silence Therapeutics plc
vs
ANNX
Annexon, Inc.
19.76
pre 19.76
delayed
Price
4.07
pre 4.09
delayed
$933.1M
Mkt cap
$828.0M
Q1 FY26
$422,000
Revenue
—
FY25
$559,000
Revenue
—
Change
Change
SLN
19.76
vs
ANNX
4.07
Pre-market
Oct 30 '26
delayed
Earnings history
last 4 reports each · paired by recency
Method
›
SLN
No earnings history for SLN.
ANNX
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±11.9%
▼
−0.19%
×0.02
May 8 '26
±53.1%
▲
+3.08%
×0.06
Q1 FY26
±13.7%
▲
+11.69%
×0.85
Q3 FY25
±15.8%
▼
−0.34%
×0.02
= implied
SLN realized, solid
ANNX realized, hatched
One scale, both sides: full bar = 54%
× = |realized| ÷ implied
Source: market data